Stock Traders Purchase Large Volume of Put Options on LifeStance Health Group (NASDAQ:LFST)

LifeStance Health Group, Inc. (NASDAQ:LFST) was the recipient of unusually large options trading on Tuesday. Stock traders bought 4,000 put options on the stock. This is an increase of 292% compared to the typical volume of 1,020 put options.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on LFST. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Monday, December 16th. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $8.63.

LifeStance Health Group Stock Down 0.5 %

NASDAQ:LFST opened at $6.63 on Wednesday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group has a twelve month low of $4.64 and a twelve month high of $8.61. The company has a market cap of $2.55 billion, a PE ratio of -25.50 and a beta of 1.27. The company’s 50 day moving average is $7.55 and its two-hundred day moving average is $7.35.

Insider Transactions at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. This trade represents a 5.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 6.60% of the company’s stock.

Institutional Investors Weigh In On LifeStance Health Group

A number of large investors have recently made changes to their positions in the stock. Wellington Management Group LLP lifted its position in LifeStance Health Group by 9.2% during the 4th quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company’s stock worth $38,886,000 after acquiring an additional 445,796 shares during the period. Forum Financial Management LP purchased a new position in shares of LifeStance Health Group in the fourth quarter worth about $110,000. Neo Ivy Capital Management lifted its holdings in shares of LifeStance Health Group by 26,132.3% during the fourth quarter. Neo Ivy Capital Management now owns 182,052 shares of the company’s stock worth $1,341,000 after purchasing an additional 181,358 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in LifeStance Health Group by 16.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 604,321 shares of the company’s stock valued at $4,454,000 after buying an additional 87,502 shares during the last quarter. Finally, Vident Advisory LLC purchased a new stake in shares of LifeStance Health Group in the 4th quarter valued at $156,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.